An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis.
Melum
Espen
E
Karlsen
Tom H
TH
Bergquist
Annika
A
Schrumpf
Erik
E
Boberg
Kirsten M
KM
D001650:Bile Duct Neoplasms / Q000097:blood / Q000235:genetics*; D001653:Bile Ducts, Intrahepatic; D015415:Biomarkers / Q000097:blood; D016009:Chi-Square Distribution; D018281:Cholangiocarcinoma / Q000097:blood / Q000235:genetics*; D015209:Cholangitis, Sclerosing / Q000097:blood / Q000235:genetics*; D005838:Genotype; D006801:Humans; D015850:Interleukin-6 / Q000097:blood / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors
D015415:Biomarkers; D015850:Interleukin-6